Charles Austin - Net Worth and Insider Trading

Charles Austin Net Worth

The estimated net worth of Charles Austin is at least $1,808 dollars as of 2024-11-13. Charles Austin is the Director of Marinus Pharmaceuticals Inc and owns about 5,277 shares of Marinus Pharmaceuticals Inc (MRNS) stock worth over $1,808. Details can be seen in Charles Austin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Charles Austin has not made any transactions after 2023-02-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Charles Austin

To

Charles Austin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Charles Austin owns 1 companies in total, including Marinus Pharmaceuticals Inc (MRNS) .

Click here to see the complete history of Charles Austin’s form 4 insider trades.

Insider Ownership Summary of Charles Austin

Ticker Comapny Transaction Date Type of Owner
MRNS Marinus Pharmaceuticals Inc 2023-02-06 director

Charles Austin Latest Holdings Summary

Charles Austin currently owns a total of 1 stock. Charles Austin owns 5,277 shares of Marinus Pharmaceuticals Inc (MRNS) as of February 6, 2023, with a value of $1,808.

Latest Holdings of Charles Austin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MRNS Marinus Pharmaceuticals Inc 2023-02-06 5,277 0.34 1,808

Holding Weightings of Charles Austin


Charles Austin Form 4 Trading Tracker

According to the SEC Form 4 filings, Charles Austin has made a total of 1 transactions in Marinus Pharmaceuticals Inc (MRNS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Marinus Pharmaceuticals Inc is the sale of 1,073 shares on February 6, 2023, which brought Charles Austin around $6,964.

Insider Trading History of Charles Austin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Charles Austin Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Charles Austin Ownership Network

Ownership Network List of Charles Austin

No Data

Ownership Network Relation of Charles Austin

Insider Network Chart

Charles Austin Owned Company Details

What does Marinus Pharmaceuticals Inc do?

Who are the key executives at Marinus Pharmaceuticals Inc?

Charles Austin is the director of Marinus Pharmaceuticals Inc. Other key executives at Marinus Pharmaceuticals Inc include Chief Commercial Officer Christina Shafer , CFO Steven Pfanstiel , and Chief Medical Officer Joseph Hulihan .

Marinus Pharmaceuticals Inc (MRNS) Insider Trades Summary

Over the past 18 months, Charles Austin made no insider transaction in Marinus Pharmaceuticals Inc (MRNS). Other recent insider transactions involving Marinus Pharmaceuticals Inc (MRNS) include a net sale of 18,588 shares made by Scott Braunstein , a net sale of 7,730 shares made by Joseph Hulihan , and a net sale of 7,461 shares made by Steven Pfanstiel .

In summary, during the past 3 months, insiders sold 0 shares of Marinus Pharmaceuticals Inc (MRNS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 45,796 shares of Marinus Pharmaceuticals Inc (MRNS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 45,796 shares.

Marinus Pharmaceuticals Inc (MRNS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Marinus Pharmaceuticals Inc Insider Transactions

No Available Data

Charles Austin Mailing Address

Above is the net worth, insider trading, and ownership report for Charles Austin. You might contact Charles Austin via mailing address: 5 Radnor Corporate Center Ste 500, 100 Matsonford Rd, Radnor Pa 19087.